The aim of this study was to determine the effect of prepartum somatotropin injection in late-pregnant Holstein heifers on metabolism, milk production and resumption of postpartum ovulation. For this study, 31 late-pregnant Holstein heifers were used. The heifers were assigned randomly into two treatments: (1) 500 mg sc injections of somatotropin (somatotropin treatment, n 5 15) at 235 and 221 days, and, if pertinent, at 27 days from expected calving date and (2) no treatment (control group, n 5 16). Blood samples were collected weekly from 25 to 7 weeks after calving. Heifers with progesterone concentrations in plasma above 1 ng/ml in two consecutive postpartum samples were considered as having resumed ovarian activity. A higher proportion (P 5 0.04) of heifers treated with somatotropin resumed ovarian activity in the first 7 weeks post partum (73.3%; 11/15) compared with the control group (37.5%; 6/16). A higher number (P 5 0.02) of heifers in the somatotropin treatment group also ovulated during the first postpartum follicular wave (53.3%; 8/15) compared with the control group (12.5%; 2/16), as indicated by the number of heifers ovulating in the first 3 weeks post partum. Pregnancy rate was not affected by treatments (P . 0.10) and averaged 40.0% (6/15) in somatotropin-treated and 25.0% (4/16) in control heifers when evaluated up to 150 days in milk. Somatotropin treatment increased the average daily milk production by 2.8 kg/cow per day (P , 0.0001) and reduced the somatic cell count (P 5 0.009). Plasma IGF-I was higher (P , 0.05) for somatotropin-treated heifers in the prepartum period. Insulin and body condition score were higher (P , 0.05) and non-esterified fatty acids were lower (P , 0.05) for somatotropin-treated cows in the early postpartum period. In conclusion, somatotropin injection during the prepartum period in late-pregnant Holstein heifers was able to increase the proportion of heifers resuming ovarian activity early post partum, inspite of higher milk production.
Introduction
During the early postpartum period, high-producing cows experience a period of negative energy balance (NEB) that occurs as the requirements for milk production exceed the -E-mail: augusto.schneider@live.com energy obtained through feeding (Butler, 2003) . In early postpartum dairy cows, the duration and intensity of NEB, the level of body condition score (BCS) loss and the milk yield are strongly associated with the timing of the first ovulation (Butler, 2003; Wathes et al., 2007) . Moreover, cows that ovulated earlier and had more estrous cycles before the first artificial insemination (AI) had a higher conception rate (Thatcher and Wilcox, 1973) . As a consequence, strategies that minimize NEB and BCS loss in the early postpartum period could have a positive impact on the timing of the first ovulation and conception rate.
Supplementing cows with low doses of somatotropin during the periparturient period has been associated with beneficial effects on the physiological adaptations and liver function (Gulay et al., 2003 and . Somatotropin has direct effects on the partitioning of nutrients to target tissues (Bauman and Vernon, 1993) , as well as indirect effects expressed in the mammary gland and other tissues that are mediated by IGF-I (Jones and Clemmons, 1995) . In this regard, somatotropin injection during the peripartum period is able to increase serum IGF-I concentration and milk production (Putnam et al., 1999; Gulay et al., 2004; Carriquiry et al., 2009b) . In addition, injection of somatotropin exclusively in the prepartum period can also lead to increased dry matter intake (DMI) in the early postpartum period (Putnam et al., 1999) . These studies indicate that prepartum injection of somatotropin is a potential tool to improve metabolic adaptation of transition dairy cows, and thus can have a positive impact on early postpartum ovulation.
Somatotropin plays a pivotal role in stimulating liver production of IGF-I (Jones and Clemmons, 1995) . Circulating IGF-I is highly related to the extent of NEB (Lucy et al., 2001; Wathes et al., 2007) , and concentrations start to decline in the third trimester of lactation, reaching a nadir at calving (Knight, 2001) . Elevated plasma concentration of IGF-I is beneficial because it acts as a modulator of gonadotropin action in the ovary, stimulating granulosa and theca cell proliferation and differentiation (Armstrong and Webb, 1997) and preventing follicular atresia (el-Roeiy et al., 1994) . Dairy cows that ovulated the first postpartum dominant follicle had higher serum IGF-I concentration in the prepartum and postpartum periods (Butler et al., 2006; Kawashima et al., 2007) . However, somatotropin injection starting at 10 days post partum had no effect on the interval from calving to first ovulation (Carriquiry et al., 2009a) . Nevertheless, the number of recruited follicles is increased in dry cows or heifers injected with somatotropin (Gong et al., 1991 and Kirby et al., 1997) . This effect persisted for at least 21 days after termination of treatment (Kirby et al., 1997) . These lines of evidence indicate that prepartum somatotropin injection can have beneficial effects on follicular development in the early postpartum period.
On the basis of previous research, the hypothesis of this study is that the better adaptation provided by prepartum somatotropin injection in late-pregnant Holstein heifers would lead to earlier postpartum resumption of ovarian activity and increased milk production.
Material and methods
All procedures carried out in this experiment were approved by the Committee for Ethics in Animal Experimentation from the Universidade Federal de Pelotas (Pelotas, RS, Brazil).
Experimental design For this study, 31 late-pregnant Holstein heifers in a commercial dairy herd in southern Brazil (328 16' S, 528 32' E) were used. The heifers had a mean BW of 568.8 6 47.8 kg and BCS of 3.4 6 0.4 (ranging from 2.5 to 4.0) at the beginning of the experiment. All calvings occurred in a 30-day interval during the winter season.
At 235 days from expected calving, the heifers were assigned randomly into two groups: (1) 500 mg somatotropin (500 mg/2 ml; Boostin R , LG Life Sciences, Seoul, Korea) by sc injections (somatotropin-treated group, n 5 15) at 235 and 221 days, and, if pertinent, at 27 days (eight heifers that did not anticipate calving) from expected calving date; and (2) no treatment (control group, n 5 16). All heifers were managed under the same conditions and nutritional regimen (Table 1) .
Sample collection, measurement and analyses Blood samples were collected weekly from 25 to 7 weeks after calving via venipuncture of the jugular vein into two tubes: one containing EDTA and potassium fluoride and the other without an anticoagulant. Samples were collected in the interval after milking and before feeding. In the postpartum period, heifers were milked twice on a daily basis at 0330 and 1530 h and production was recorded daily (Alpro R , DeLaval, Kansas City, MO, USA) and combined for weekly averages. BW was estimated weekly using a chest tape and BCS was evaluated weekly by one technician.
Concentrations of glucose and non-esterified fatty acids (NEFA) were measured colorimetrically using commercial kits, Glucose PAP Liquiform (Labtest Diagnostica, Lagoa Santa, SP, Brazil; Tabeleã o et al., 2008) and NEFA-HR (Wako USA, Richmond, VA, USA) using the micro-method described by Ballou et al. (2009) . The intra-and inter-assay coefficients of variation (CV) for glucose and NEFA were ,10%.
The procedures for IGF-I, insulin and progesterone analysis followed those specified by the manufacturer. Plasma IGF-I and insulin concentrations were measured using sandwich-type immunoassay commercial kits, DSL-10-2800 ACTIVE Non-extraction IGF-I ELISA (Obese et al., 2008) and DSL-10-1600 ACTIVE Insulin (Diagnostics Systems Laboratories Inc., Webster, TX, USA; Lee et al., 2002) , respectively. The intra-assay CV was 4.2% and 4.0% and the inter-assay CV 8.5% and 13.0% for IGF-I and insulin, respectively.
Progesterone concentrations in plasma were measured using a solid-phase ELISA that is based on the principle of competitive binding using a commercial kit, Progesterone IB79105 (Immuno-Biological Laboratories Inc., Minneapolis, MN, USA; Colazo et al., 2008) . The intra-assay CV was 9.9% and the inter-assay CV was 5.5%. Only the plasma samples collected from weeks 2 to 7 were analyzed. Heifers with progesterone concentrations in plasma above 1 ng/ml in Schneider, Schwegler, Montagner, Hax, Schmitt, Pfeifer, Del Pino, Bianchi, Paludo and Corrê a two consecutive samples were considered as having resumed ovarian activity (Stevenson and Britt, 1979) .
Composite milk samples were collected weekly at the afternoon milking. Milk protein, fat and lactose assays were carried out using IR spectrophotometry (Bentley 20000, Bentley Instruments Inc., Chaska, MN, USA). The somatic cell count (SCC) assay was carried out using flow cytometry (Somacount 300, Bentley Instruments Inc.).
Reproductive management After 50 days in milk (DIM), estrus was detected by visual observation and cows presenting visual signs of estrous behavior (standing when mounted) were artificially inseminated (AI). Visual observation of estrous behavior and AI were carried out by the same technician. Pregnancy diagnosis was carried out using ultrasound 30 days after AI and rechecked 60 days later.
Statistical analyses
The results are presented as means 6 standard error of the mean (s.e.m.). All statistical analyses were carried out using SAS (SAS Institute Inc., Cary, NC, USA). Analyses involving repeated measures over time (e.g. BCS, BW, glucose, NEFA, insulin, IGF-I, milk production and composition) were compared between treatments using ANOVA for repeated measures using the MIXED procedure to evaluate the main effects of time, treatment and their interactions (Littell et al., 1998) . SCC values were log transformed before analysis. The statistical models and data analyses were designed and carried out separately for the prepartum and postpartum periods. When the interaction between treatment and time was significant (P , 0.05), pair-wise comparison of individual means was conducted. Percentage of cows ovulating before 3 and 7 weeks was analyzed using x 2 -test. Pregnancy rate was evaluated using the CAT MOD procedure for repeated measures at 60, 100, 120 and 150 DIM. A value of P , 0.05 was considered significant and a value of between 0.05 and <0.1 was considered as a tendency.
Results
A higher proportion (P 5 0.04) of heifers treated with somatotropin resumed ovarian activity in the first 7 weeks post partum (73.3%; 11/15) compared with the control group (37.5%; 6/16). A higher number of heifers in the somatotropin treatment group also ovulated (P 5 0.02) the first postpartum dominant follicle (53.3%; 8/15) compared with the control group (12.5%; 2/16), as indicated by the number of heifers ovulating in the first 3 weeks post partum. Concentrations of progesterone for ovulatory and non-ovulatory heifers are represented in Figure 1 . For non-ovulatory heifers, progesterone concentrations were never higher than 1 ng/ml. Pregnancy rate was not different (P 5 0.30) between somatotropintreated (40.0%; 6/15) heifers and control heifers (25.0%; 4/16) when evaluated up to 150 DIM.
Data for milk production and composition are summarized in Table 2 . Somatotropin treatment increased the average daily milk production (P , 0.0001) and reduced the SCC (P 5 0.009).
Data for plasma variables are summarized in Figure 2 . Briefly, we did not detect an effect of week of study, treatment or treatment 3 week interaction on prepartum plasma glucose concentrations. For postpartum glucose, there was only an effect of time (P 5 0.0004) with plasma glucose being higher (P , 0.02) at week 1. For plasma IGF-I concentration, there was a week (P 5 0.002), treatment (P 5 0.03) and week 3 treatment (P 5 0.03) effect. Plasma IGF-I was higher for somatotropin-treated heifers at weeks 24 and 23. There was only an effect of week (P 5 0.002) for postpartum IGF-I concentrations, being higher (P , 0.05) at weeks 5, 6 and 7 than at weeks 1 and 3. For prepartum insulin, there was an effect of week (P , 0.0001) and treatment (P 5 0.002). Insulin concentrations were higher (P , 0.05) at weeks 25 and 24 and were higher (P , 0.05) for somatotropin-treated heifers. Postpartum insulin concentrations were higher (P 5 0.01) for somatotropin-treated heifers and were higher (P , 0.05) at weeks 6 and 7.
We detected an effect of the week for prepartum (P 5 0.0006) and postpartum (P 5 0.0006) BCS. For the prepartum period, BCS was higher (P , 0.05) at week 25 and there was no effect of treatment (P 5 0.93). For the postpartum period, BCS was lower (P , 0.05) at weeks 6 and 7. Postpartum BCS was higher for somatotropin-treated heifers (2.7 6 0.02) than in control heifers (2.6 6 0.02; P 5 0.02). Effects for the treatment, week or treatment 3 week interaction for prepartum (560.3 6 9.2 kg) or postpartum (530.3 6 5.7 kg) BW were not significant.
Discussion
As hypothesized, prepartum somatotropin treatment reduced intensity of NEB as observed by increased insulin and reduced NEFA concentrations and BCS loss in the postpartum period.
Consequently, prepartum somatotropin increased milk production and the proportion of heifers ovulating in the first 7 weeks post partum. Despite the positive effects in the resumption of ovarian activity, we did not find any significant increase in the pregnancy rate for treated heifers, probably because of low statistical power and number of heifers enrolled in this study.
Somatotropin treatment increased the number of heifers resuming ovarian activity in the first 7 weeks post partum. In addition, more heifers in this treatment ovulated the first postpartum dominant follicle, as indicated by the rise in progesterone concentration before 21 DIM (Kawashima et al., 2006) . It is well-established that cows ovulating during the first postpartum follicular wave have higher serum IGF-I concentration in the prepartum and postpartum periods (Butler et al., 2006; Kawashima et al., 2007) . In this study, heifers treated with somatotropin had higher IGF-I concentration in the prepartum period, but not in the postpartum period. Britt (1992) hypothesized that the developmental competence of the oocyte and the steroidogenic capacity of the follicle, in high yielding dairy cows, is determined by their biochemical environment during the long period (up to 80 days) of follicular growth before ovulation. Thus, primary follicles exposed to adverse conditions associated with the metabolically challenging period of NEB during the early postpartum period may be less capable of producing adequate amounts of estrogens. Furthermore, such follicles would be doomed to contain an inferior oocyte, which will then be ovulated approximately 60 to 80 days post partum (Leroy et al., 2008) .
Although this hypothesis was never tested with regard to the NEB challenge, it was found to be true for cows undergoing a short period of heat stress (Roth et al., 2001a and 2001b) and can explain the effects of prepartum IGF-I on postpartum follicle development observed in this study.
Another interesting point is that somatotropin-treated heifers had higher insulin concentrations in the postpartum period. Circulating insulin concentration is proposed as a key factor in mediating the effect of dietary intake on ovarian function (Armstrong et al., 2002) . In this manner, dairy cows fed diets designed to increase circulating insulin concentrations demonstrated increased ovarian function (Armstrong et al., 2001 ) and earlier onset of estrous cycles . In addition, cows that ovulated the first postpartum dominant follicle had higher circulating insulin concentrations Figure 1 Plasma progesterone concentrations from 2 to 7 weeks after calving for somatrotopin-treated (K) or control heifers (J) that ovulated (----) or not (--). The dashed line (----) indicates the 1 ng/ml limit used to divide cows that were considered as ovulatory or non-ovulatory. Heifers were treated with 500 mg of recombinant bovine somatotropin at weeks 25 and 23 from calving. than anovulatory cows (Butler et al., 2006) . The increased ovulation rate is probably due to positive effects of insulin on steroidogenesis (Butler et al., 2004 ) via amplification of gonadotropin action (Spicer and Echternkamp, 1995) . Milk production was increased by prepartum somatotropin treatment, in agreement with a previous observation (Putnam et al., 1999) . In the same way, prepartum injection of somatotropin in ewes led to higher milk production and mammary cell proliferation (Stelwagen et al., 1993) , probably mediated by IGF-I (Baumrucker and Stemberger, 1989) . Furthermore, according to the SCC data, the health of the mammary gland was also improved in heifers injected with somatotropin. The decreased SCC in dairy cows receiving somatotropin has already been shown elsewhere (Putnam et al., 1999; Gulay et al., 2004) , and can also have contributed to increased milk production (Hortet et al., 1999) .
Previous studies have shown that cows treated with a low dose of somatotropin in the peripartum period had a better recovery of BCS during early lactation, even though they produced more milk (Putnam et al., 1999; Gulay et al., 2003) . Studies indicate that the extra energy to support increased milk yield in somatotropin-treated cows arose from greater DMI rather than from greater mobilization of body reserves (Putnam et al., 1999; Gulay et al., 2004) . In agreement with these observations, in this study, somatotropin-treated heifers had lower BCS loss and better energy balance related parameters, such as higher insulin and lower NEFA concentrations in the early postpartum period, even though they produced more milk. Vallimont et al. (2001) also found a reduction in postpartum NEFA concentration after injecting cows with somatotropin exclusively in the prepartum period, in concert with our current findings.
In conclusion, somatotropin injection during the prepartum period in late-pregnant Holstein heifers increased proportion of heifers resuming ovarian activity during the first 7 weeks post partum, inspite of higher milk production. In addition, prepartum somatotropin also improved parameters that indicate that these heifers had a less severe NEB during the early postpartum period. Figure 2 Plasma concentrations of glucose (mg/dl) (a), IGF-I (ng/ml) (b), non-esterified fatty acids (NEFA; mmol/l) (c) and insulin (mIU/ml) (d) from 25 to 7 weeks from calving for somatrotopin-treated (K) or control heifers (J). Heifers were treated with 500 mg of recombinant bovine somatotropin at weeks 25 and 23 from calving.
